Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
29
GBIO Quote, Financials, Valuation and Earnings
Last price:
$5.34
Seasonality move
:
4.6%
Day range:
$5.34 - $5.34
52-week range:
$3.00 - $7.35
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
7.62x
P/B ratio:
0.71x
Volume:
--
Avg. volume:
93.6K
1-year change:
-23.11%
Market cap:
$35.8M
Revenue:
$19.9M
EPS (TTM):
-$7.36
Analysts' Opinion
-
Consensus RatingGeneration Bio Co. has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $5.00, Generation Bio Co. has an estimated downside of -6.37% from its current price of $5.34.
-
Price Target UpsideAccording to analysts, the highest upside price target is $5.00 representing -100% upside increase from its current price of $5.34.
Fair Value
-
According to the consensus of 2 analysts, Generation Bio Co. has -6.37% downside to fair value with a price target of $5.00 per share.
GBIO vs. S&P 500
-
Over the past 5 trading days, Generation Bio Co. has underperformed the S&P 500 by -0.66% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Generation Bio Co. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Generation Bio Co. revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Generation Bio Co. reported revenues of $1.6M.
Earnings Growth
-
Generation Bio Co. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Generation Bio Co. reported earnings per share of -$0.82.
Enterprise value:
-27.7M
EV / Invested capital:
--
Price / LTM sales:
7.62x
EV / EBIT:
--
EV / Revenue:
-1.82x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
0.24x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$10.4M
Return On Assets:
-31.87%
Net Income Margin (TTM):
-410.13%
Return On Equity:
-84.94%
Return On Invested Capital:
-41.48%
Operating Margin:
-1348.68%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $3M | $18.6M | $15.3M | $7.6M | $1.6M | |
| Gross Profit | -$2.3M | $13.5M | $10.4M | $6.4M | $190K | |
| Operating Income | -$135.1M | -$90.2M | -$78.3M | -$16.7M | -$21.5M | |
| EBITDA | -$129.8M | -$85.1M | -$73.4M | -$15.5M | -$20.1M | |
| Diluted EPS | -$1.98 | -$2.19 | -$7.36 | -$0.23 | -$0.82 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $403.3M | $310.6M | $297.8M | $191.3M | $93.5M | |
| Total Assets | $464M | $402.8M | $381.5M | $248.8M | $121.9M | |
| Current Liabilities | $14.5M | $17.3M | $32.8M | $30.2M | $21M | |
| Total Liabilities | $56.8M | $94.1M | $149.6M | $144.3M | $71.3M | |
| Total Equity | $407.2M | $308.7M | $231.9M | $104.4M | $50.6M | |
| Total Debt | $42.3M | $76.7M | $71M | $83M | $19.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$50.8M | -$97.8M | -$113.7M | -$19.5M | -$52.7M | |
| Cash From Investing | -$26.2M | $22.3M | $113.7M | $12.7M | $25.5M | |
| Cash From Financing | $35.8M | $183K | $215K | -$3K | -$2K | |
| Free Cash Flow | -$54.3M | -$104.4M | -$114.7M | -$19.6M | -$52.7M | |
GBIO
Sector
Market Cap
$35.8M
$25.6M
Price % of 52-Week High
72.69%
49.47%
Dividend Yield
0%
0%
Shareholder Yield
32.52%
-1.77%
1-Year Price Total Return
-23.11%
-21.96%
Beta (5-Year)
2.046
0.499
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$5.34
200-day SMA
Buy
Level
$5.11
Bollinger Bands (100)
Sell
Level
5.23 - 6.01
Chaikin Money Flow
Buy
Level
2.8M
20-day SMA
Sell
Level
$5.52
Relative Strength Index (RSI14)
Sell
Level
39.71
ADX Line
Sell
Level
17.46
Williams %R
Buy
Level
-100
50-day SMA
Sell
Level
$5.51
MACD (12, 26)
Sell
Level
-0.06
25-day Aroon Oscillator
Sell
Level
-4
On Balance Volume
Neutral
Level
14.1M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-4.1763)
Sell
CA Score
(Annual)
Level (-1.7091)
Buy
Beneish M-Score
(Annual)
Level (-2.5018)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (3.6723)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Stock Forecast FAQ
In the current month, GBIO has received 0 Buy ratings 2 Hold ratings, and 0 Sell ratings. The GBIO average analyst price target in the past 3 months is $5.00.
-
Where Will Generation Bio Co. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Generation Bio Co. share price will drop to $5.00 per share over the next 12 months.
-
What Do Analysts Say About Generation Bio Co.?
Analysts are divided on their view about Generation Bio Co. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Generation Bio Co. is a Sell and believe this share price will rise from its current level to $5.00.
-
What Is Generation Bio Co.'s Price Target?
The price target for Generation Bio Co. over the next 1-year time period is forecast to be $5.00 according to 2 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is GBIO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Generation Bio Co. is a Hold. 2 of 2 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of GBIO?
You can purchase shares of Generation Bio Co. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Generation Bio Co. shares.
-
What Is The Generation Bio Co. Share Price Today?
Generation Bio Co. was last trading at $5.34 per share. This represents the most recent stock quote for Generation Bio Co.. Yesterday, Generation Bio Co. closed at $5.34 per share.
-
How To Buy Generation Bio Co. Stock Online?
In order to purchase Generation Bio Co. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get GBIO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GBIO
Sector
P/E ratio
--
23.36x
PEG ratio
0.00x
-0.01x
P/B ratio
0.71x
1.78x
Price / LTM sales
7.62x
1.56x
Growth Metrics
GBIO
Sector
Revenue growth
-78.9%
3.51%
Earnings growth
-257.24%
9.66%
Revenue (5-year growth)
177.31%
6.45%
Earnings forecast
-$2.67
-$0.19
Profitability
GBIO
Sector
Profitability FY 2024
$15M
$2.6M
Return on invested capital
-41.48%
-33.43%
Return on assets
-31.87%
-29.68%
Return on equity
-84.94%
-38.71%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Mar
12
Estimated Next Earnings Date
Feb
4
Balance Sheet
GBIO
Sector
Total cash
$89.6M
$25M
Short term investments
$108.9M
$24M
Total assets
$231.2M
$71.9M
Long term debt
$19.7M
$2.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
77
RNG alert for Feb 23
RingCentral, Inc. [RNG] is down 12.48% over the past day.
Sell
9
FROG alert for Feb 23
JFrog Ltd. [FROG] is down 7.95% over the past day.
Buy
72
SNSE alert for Feb 23
Sensei Biotherapeutics, Inc. [SNSE] is down 2.63% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
